These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 30147363)
1. Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer. Li Y; Cui X; Li Y; Zhang T; Li S Cancer Manag Res; 2018; 10():2627-2633. PubMed ID: 30147363 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer. Fu Y; Li Y; Wang X; Li F; Lu Y Cancer Biomark; 2020; 27(2):147-156. PubMed ID: 31771046 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer. Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer. Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells. Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-374b-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer by Targeting FOXP1 and Predicts Prognosis of Cancer Patients. Li J; Zhang X; Tang J; Gong C Onco Targets Ther; 2020; 13():4229-4237. PubMed ID: 32523358 [TBL] [Abstract][Full Text] [Related]
7. MiR-519a functions as a tumor suppressor and is negatively associated with poor prognosis of non-small cell lung cancer. Wang Y; Jiang F; Wang J; Fu Y; Li Y; Li F Cancer Biomark; 2020; 28(1):121-128. PubMed ID: 32224524 [TBL] [Abstract][Full Text] [Related]
8. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406 [TBL] [Abstract][Full Text] [Related]
9. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer. Li W; Cui Y; Wang D; Wang Y; Wang L Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-518b in non-small cell lung cancer serves as a biomarker and facilitates tumor cell proliferation, migration and invasion. Zhang X; Hu Y; Gong C; Zhang C Oncol Lett; 2020 Aug; 20(2):1213-1220. PubMed ID: 32724361 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer. Chen SW; Wang TB; Tian YH; Zheng YG Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832 [TBL] [Abstract][Full Text] [Related]
13. Prognosis and Biological Function of miR-3195 in Non-Small Cell Lung Cancer. Lu Y; Zhang X; Zhang H; Zhu Z Cancer Manag Res; 2022; 14():169-176. PubMed ID: 35046724 [TBL] [Abstract][Full Text] [Related]
14. Upregulated miR-665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion. Xia J; Li D; Zhu X; Xia W; Qi Z; Li G; Xu Q Oncol Lett; 2020 May; 19(5):3578-3586. PubMed ID: 32269632 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of miR-1181 in non-small cell lung cancer and its regulatory effect on tumor progression. Liu F; Ma G; Wang B; Wang X; Huang C Exp Ther Med; 2021 Nov; 22(5):1284. PubMed ID: 34630639 [TBL] [Abstract][Full Text] [Related]
16. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
17. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance. Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608 [TBL] [Abstract][Full Text] [Related]
18. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival. Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781 [TBL] [Abstract][Full Text] [Related]
19. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer. Zhu J; Zhang Y; Yang X; Jin L Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208 [TBL] [Abstract][Full Text] [Related]
20. miR-1290 is a potential prognostic biomarker in non-small cell lung cancer. Mo D; Gu B; Gong X; Wu L; Wang H; Jiang Y; Zhang B; Zhang M; Zhang Y; Xu J; Pan S J Thorac Dis; 2015 Sep; 7(9):1570-9. PubMed ID: 26543604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]